Literature DB >> 25960150

Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers.

Cristina Carvalho1, Maria S Santos2, Catarina R Oliveira3, Paula I Moreira4.   

Abstract

We aimed to investigate mitochondrial function, biogenesis and autophagy in the brain of type 2 diabetes (T2D) and Alzheimer's disease (AD) mice. Isolated brain mitochondria and homogenates from cerebral cortex and hippocampus of wild-type (WT), triple transgenic AD (3xTg-AD) and T2D mice were used to evaluate mitochondrial functional parameters and protein levels of mitochondrial biogenesis, autophagy and synaptic integrity markers, respectively. A significant decrease in mitochondrial respiration, membrane potential and energy levels was observed in T2D and 3xTg-AD mice. Also, a significant decrease in the levels of autophagy-related protein 7 (ATG7) and glycosylated lysosomal membrane protein 1 (LAMP1) was observed in cerebral cortex and hippocampus of T2D and 3xTg-AD mice. Moreover, both brain regions of 3xTg-AD mice present lower levels of nuclear respiratory factor (NRF) 1 while the levels of NRF2 are lower in both brain regions of T2D and 3xTg-AD mice. A decrease in mitochondrial encoded, nicotinamide adenine dinucleotide dehydrogenase subunit 1 (ND1) was also observed in T2D and 3xTg-AD mice although only statistically significant in T2D cortex. Furthermore, a decrease in the levels of postsynaptic density protein 95 (PSD95) in the cerebral cortex of 3xTg-AD mice and in hippocampus of T2D and 3xTg-AD mice and a decrease in the levels of synaptosomal-associated protein 25 (SNAP 25) in the hippocampus of T2D and 3xTg-AD mice were observed suggesting synaptic integrity loss. These results support the idea that alterations in mitochondrial function, biogenesis and autophagy cause synaptic damage in AD and T2D.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Autophagy; Mitochondrial function and biogenesis; Synaptic integrity; Type 2 diabetes

Mesh:

Substances:

Year:  2015        PMID: 25960150     DOI: 10.1016/j.bbadis.2015.05.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

1.  Vildagliptine protects SH-SY5Y human neuron-like cells from Aβ 1-42 induced toxicity, in vitro.

Authors:  Alim Hüseyin Dokumacı; Mukerrem Betul Yerer Aycan
Journal:  Cytotechnology       Date:  2019-04-09       Impact factor: 2.058

2.  Autophagy impairment mediated by S-nitrosation of ATG4B leads to neurotoxicity in response to hyperglycemia.

Authors:  Yazi Li; Yuying Zhang; Lei Wang; Ping Wang; Yanhong Xue; Xiaopeng Li; Xinhua Qiao; Xu Zhang; Tao Xu; Guanghui Liu; Peng Li; Chang Chen
Journal:  Autophagy       Date:  2017-07-03       Impact factor: 16.016

3.  Type-2 diabetes mellitus reduces cortical thickness and decreases oxidative metabolism in sensorimotor regions after stroke.

Authors:  Jennifer K Ferris; Sue Peters; Katlyn E Brown; Katherine Tourigny; Lara A Boyd
Journal:  J Cereb Blood Flow Metab       Date:  2017-04-12       Impact factor: 6.200

4.  Silibinin ameliorates Aβ25-35-induced memory deficits in rats by modulating autophagy and attenuating neuroinflammation as well as oxidative stress.

Authors:  Xiaoyu Song; Biao Zhou; Lingyu Cui; Di Lei; Pingping Zhang; Guodong Yao; Mingyu Xia; Toshihiko Hayashi; Shunji Hattori; Yuko Ushiki-Kaku; Shin-Ichi Tashiro; Satoshi Onodera; Takashi Ikejima
Journal:  Neurochem Res       Date:  2016-12-22       Impact factor: 3.996

Review 5.  ER stress and impaired autophagy flux in neuronal degeneration and brain injury.

Authors:  Yan Yin; George Sun; Eric Li; Kirill Kiselyov; Dandan Sun
Journal:  Ageing Res Rev       Date:  2016-09-01       Impact factor: 10.895

Review 6.  [Mitophagy and nervous system disease].

Authors:  Ming-Xi Li; De-Zhi Mu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2017-06

Review 7.  Novel GLP-1 (Glucagon-Like Peptide-1) Analogues and Insulin in the Treatment for Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Valeria Calsolaro; Paul Edison
Journal:  CNS Drugs       Date:  2015-12       Impact factor: 5.749

Review 8.  The diabetic brain and cognition.

Authors:  Peter Riederer; Amos D Korczyn; Sameh S Ali; Ovidiu Bajenaru; Mun Seong Choi; Michael Chopp; Vesna Dermanovic-Dobrota; Edna Grünblatt; Kurt A Jellinger; Mohammad Amjad Kamal; Warda Kamal; Jerzy Leszek; Tanja Maria Sheldrick-Michel; Gohar Mushtaq; Bernard Meglic; Rachel Natovich; Zvezdan Pirtosek; Martin Rakusa; Melita Salkovic-Petrisic; Reinhold Schmidt; Angelika Schmitt; G Ramachandra Sridhar; László Vécsei; Zyta Beata Wojszel; Hakan Yaman; Zheng G Zhang; Tali Cukierman-Yaffe
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

9.  Retina and Brain Display Early and Differential Molecular and Cellular Changes in the 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Ana Catarina Rodrigues-Neves; Rafael Carecho; Sónia Catarina Correia; Cristina Carvalho; Elisa Julião Campos; Filipa Isabel Baptista; Paula Isabel Moreira; António Francisco Ambrósio
Journal:  Mol Neurobiol       Date:  2021-02-19       Impact factor: 5.590

Review 10.  Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis.

Authors:  Mark V Pinti; Garrett K Fink; Quincy A Hathaway; Andrya J Durr; Amina Kunovac; John M Hollander
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-02       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.